Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Varicella [chickenpox] |
French
|
Varicelle |
| Level | Code | Title | |
|---|---|---|---|
| 1 | I | Certain infectious and parasitic diseases | |
| 2 | B00-B09 | Viral infections characterized by skin and mucous membrane lesions | |
| 3 | B01 | Varicella [chickenpox] |
| Code | Title | |
|---|---|---|
| B01.0 | Varicella meningitis | |
| B01.1 | Varicella encephalitis | |
| B01.2 | Varicella pneumonia | |
| B01.8 | Varicella with other complications | |
| B01.9 | Varicella without complication |
| Active Ingredient | Description | |
|---|---|---|
| Aciclovir |
Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation. |
|
| Minocycline |
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |
|
| Varicella, live attenuated |
Natural infection induces a cellular and humoral immune response to the varicella-zoster virus, which can be rapidly detected following infection. IgG, IgM and IgA directed against viral proteins usually appear at the same time that a cellular immune response can be demonstrated, making the relative contribution of humoral and cellular immunity to disease progression difficult to ascertain. Vaccination has been shown to induce both humoral and cell-mediated types of immunity. |
